Skip to main content
. 2022 Jan 19;14(2):229. doi: 10.3390/pharmaceutics14020229

Table A4.

Average score (0–4) for exudate for untreated wounds, wounds treated with wild type L. reuteri R2LC or ILP100 in Cohort A and wounds treated with placebo or ILP100 wounds in Cohort B. For time points not included in the table, all wounds in all groups were scored as 0. * p < 0.05.

Exudate (Mean ± SEM)
Cohort A Day 2 Day 3 Day 5 Day 7 Day 9 Day 11 Day 13 Day 19 n;N
Untreated 1.28 (± 0.11) 1.39 (± 0.16) 1.72 (± 0.11) 0.61 (± 0.12) 0.39 (± 0.14) 0.17 (± 0.09) 0.00 (± 0.00) 0.00 (± 0.00) 3;18
Wild type R2LC 0.83 (± 0.11) * 0.67 (± 0.14) * 0.92 (± 0.15) * 0.17 (± 0.11) 0.25 (± 0.13) 0.08 (± 0.08) 0.00 (± 0.00) 0.08 (± 0.08) 3;12
ILP100 0.63 (± 0.09) * 0.67 (± 0.10) * 0.80 (± 0.12) * 0.57 (± 0.11) 0.50 (± 0.10) 0.03 (± 0.03) 0.07 (± 0.05) 0.00 (± 0.00) 6;30
Cohort B - Day 3 - Day 7 Day 9 Day 11 Day 13 - n;N
Placebo - 1.56 (± 0.12) - 1.17 (± 0.17) 0.56 (± 0.12) 0.00 (± 0.00) 0.00 (± 0.00) - 3;18
ILP100 - 1.50 (± 0.08) - 0.75 (± 0.11) 0.47 (± 0.08) 0.17 (± 0.06) 0.06 (± 0.04) - 6;36